Cyclacel Pharmaceuticals (CYCC) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-6.23
-4.27
-2.32
-0.36

Details

Expected EPS
-4.745
Actual EPS
-2.27
Surprise EPS
2.48
Surprise Percent
+52.16%

Description

Cyclacel Pharmaceuticals (CYCC) has reported earnings of -2.27 per share for Q2 2024.

0 Comments

Share your thoughts